510(k) K232017

ARK Methotrexate II Assay by Ark Diagnostics, Inc. — Product Code LAO

K232017 is an FDA 510(k) premarket notification submitted by Ark Diagnostics, Inc. for the device "ARK Methotrexate II Assay". The FDA issued a decision of Substantially Equivalent on Dec 20, 2023. The device falls under product code LAO (Enzyme Immunoassay, Methotrexate), a Class U device. Ark Diagnostics, Inc. has 16 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 20, 2023
Date Received
Jul 7, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Methotrexate
Device Class
Class U
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Ark Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K232017. Report a data issue: hello@regdatalab.com.